Concepedia

Yvonne Tomberger

YT

Statistics

Publications

3

Citations

100

H-Index

3

Active since

2022

Affiliations

Themis Bioscience (Austria)(Current)

Institut Pasteur

Centre National de la Recherche Scientifique

Inserm

Yvonne Tomberger is an author at Themis Bioscience (Austria) specializing in infectious diseases, vaccine immunology, and measles virus vectors.

Publications per year

2022–2023

3

Publications

3

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial

Roland Tschismarov, Pierre Van Damme, Clara Germain et al. · The Lancet · 2023 · 44 citations · Full text

, , +14

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study

Odile Launay, Cécile Artaud, Marie Lachâtre et al. · EBioMedicine · 2022 · 31 citations · Full text

, , +17

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

Frédéric Vanhoutte, Wen Liu, Richard T. Wiedmann et al. · EBioMedicine · 2022 · 25 citations · Full text

, , +16

1–3 of 3